|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 在中国使用左乙拉西坦和卡马西平单药治疗部分性癫痫发作的比较:一项开放性、非劣效性试验的主要结果显示文摘目的针对≥16岁、新诊断或最近诊断为部分性癫痫发作的中国患者,比较左乙拉西坦和速释卡马西平(CBZ-IR)单药治疗的疗效。方法在Ⅲ期、随机分配、开放性试验N01364(NCT01954121)中,患者按1∶1的比例随机分配接受左乙拉西坦1 000 mg/d或CBZ-IR 400 mg/d,记录6个月无癫痫发作的患者比例及患者保留率、首次癫痫发作的时间、因不良事件或缺乏疗效导致首次癫痫发作/中止试验的时间、安全性和耐受性。结果在对符合方案集进行的分析中,接受左乙拉西坦治疗的186例患者中有88例(47.3%),接受CBZ-IR治疗的171例患者中有117例(68.4%)达到6个月无癫痫发作;校正后绝对差值为-22.9%(95%CI:-33.1%,-12.6%),其下限低于非劣效性界值-20%。左乙拉西坦组的患者保留率为48.4%,CBZ-IR组为70.2%。对于评估期首次癫痫发作时间,左乙拉西坦与CBZ-IR的风险比为2.686(95%CI:1.838,3.927);对于因不良事件或缺乏疗效导致首次癫痫发作/中止试验的时间,风险比为2.338(95%CI:1.629, 3.356)。使用左乙拉西坦在治疗中出现的不良事件(61.9%)略低于CBZ-IR(67.9%)。结论在低剂量单药治疗下,无法确定左乙拉西坦的疗效不低于CBZ-IR。左乙拉西坦的安全性/耐受性情况优于CBZ-IR。 | 廖卫平 周东 Toru Osakabe Christian Loesch 杜新鲁 Frank Tennigkeit 王学峰 | 2020 | 临床神经病学杂志2020，33，5： | 8 |
| 2 | Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C显示文摘AIM: To investigate the factors other than fibrosis stage correlating with acoustic radiation force impulse(ARFI) elastograpy in chronic hepatitis C. METHODS: ARFI elastograpy was performed in 108 consecutive patients with chronic hepatitis C who underwent a liver biopsy. The proportion of fibrosis area in the biopsy specimens was measured by computerassisted morphometric image analysis. RESULTS: ARFI correlated significantly with fibrosis stage(β = 0.1865, P < 0.0001) and hyaluronic acid levels(β = 0.0008, P = 0.0039) in all patients by multiple regression analysis. Fibrosis area correlated significantly with ARFI by Spearman's rank correlation test but not by multiple regression analysis. ARFI correlated significantly with body mass index(BMI)(β =-0.0334, P = 0.0001) in F 0 or F 1, with γ-glutamyltranspeptidase levels(β = 0.0048, P = 0.0012) in F 2, and with fibrosis stage(β = 0.2921, P = 0.0044) and hyaluronic acid levels(β = 0.0012, P = 0.0025) in F 3 or F 4. The ARFI cutoff value was 1.28 m/s for F ≥ 2, 1.44 m/s for F ≥ 3, and 1.73 m/s for F 4. CONCLUSION: ARFI correlated with fibrosis stage and hyaluronic acid but not with inflammation. ARFI was affected by BMI, γ-glutamyltranspeptidase, and hyaluronic acid in each fibrosis stage. | Toru Nishikawa Senju Hashimoto Naoto Kawabe Masao Harata Yoshifumi Nitta Michihito Murao Takuji Nakano Yuko Mizuno Hiroaki Shimazaki Toshiki Kan Kazunori Nakaoka Yuka Takagawa Masashi Ohki Naohiro Ichino Keisuke Osakabe Kentaro Yoshioka | 2014 | World Journal of Gastroenterology2014，20，5： | 7 |
| 3 | A new index for non-invasive assessment of liver fibrosis显示文摘AIM:To construct and evaluate a new non-invasive fibrosis index for assessment of the stage of liver f ibrosis. METHODS:A new f ibrosis index (Fibro-Stiffness index) was developed in 165 of 285 patients with chronic hepatitis C, and was validated in the other 120 patients where liver biopsy was performed. Its usefulness was compared with liver stiffness (LS) measured by FibroScan, the aminotransferase-to-platelet ratio index, the Forns index and the FibroIndex. RESULTS: The Fibro-Stiffness index consists of LS,platelet count and prothrombin time. The values of the Fibro-Stiffness index differed signif icantly between neighboring f ibrosis stages except F0-F1. The area under the receiver operating characteristics curves of the Fibro-Stiffness index for prediction of F≥2 (0.90), F≥ 3 (0.90) and F= 4(0.92) in the estimation group and those for F≥ 3 (0.93) and F =4 (0.97) in the validation group were the highest among the 5 methods examined. The accuracy of the Fibro-Stiffness index had highest values for F≥2, F≥3 and F=4 in both the estimation and validation groups. The diagnostic performance for F= 4 was improved by a combination of the Fibro-Stiffness index with serum hyaluronic acid level. CONCLUSION: The Fibro-Stiffness index was constructed and validated. It showed superior diagnostic performance to other indices for F ≥ 2,3 and 4. | Naohiro Ichino Keisuke Osakabe Toru Nishikawa Hiroko Sugiyama Miho Kato Shiho Kitahara Senju Hashimoto Naoto Kawabe Masao Harata Yoshifumi Nitta Michihito Murao Takuji Nakano Yuko Arima Hiroaki Shimazaki Koji Suzuki Kentaro Yoshioka | 2010 | World Journal of Gastroenterology2010，16，38： | 7 |
| 4 | ICRF Heated Long-Pulse Plasma Discharges in LHD显示文摘A long-pulse plasma discharge for more than 30 min.was achieved on the LargeHelical Device(LHD).A plasma of n_e=0.8×10^(19)m^(-3)and T_(iO)=2.0 keV was sustained withP_(ICH)=0.52 MW,P_(ECH)=0.1 MW and averaged P_(NBI)=0.067 MW.Total injected heatingenergy was 1.3 GJ,which was a quarter of the prepared RF heating energy.One of the keys to thesuccess of the experiment was a dispersion of the local plasma heat load to divertors,accomplishedby shifting the magnetic axis inward and outward. | R. KUMAZAWA T. SEKI T. MUTOH K. SAITO T. WATARI Y. NAKAMURA M. SAKAMOTO T. WATANABE S. KUBO T. SHIMOZUMA Y. YOSHIMURA H. IGAMI Y. TAKEIRI Y. OKA K. TSUMORI M. OSAKABE K. IKEDA K. NAGAOKA O. KANEKO J. MIYAZAWA S. MORITA K. NARIHARA M. SHOJI S. MASUZAKI M. GOTO T. MORISAKI B. J. PETERSON K. SATO T. TOKUZAWA N. ASHIKAWA K. NISHIMURA H. FUNABA H. CHIKARAISHI T. NOTAKE Y. TORII H. OKADA M. ICHIMURA H. HIGAKI Y. TAKASE H. KASAHARA F. SHIMPO G.NOMURA C.TAKAHASHI M.YOKOTA A. KATO 赵燕平 J. S. YOON J. G. KWAK H. YAMADA K. KAWAHATA N. OHYABU K. IDA Y. NAGAYAMA N. NODA A. KOMORI S. SUDO O. MOTOJIMA | 2006 | Plasma Science and Technology2006，8，1： | 4 |
| 5 | 拉考沙胺添加治疗中国部分性癫■发作患者的疗效和安全性:一项随机双盲试验和开放标签扩展试验的亚组分析和事后分析显示文摘目的评估抗癫■药拉考沙胺添加治疗对控制不佳的部分性癫■发作成年患者的疗效和安全性。方法EP0008(NCT01710657)是一项为期24周在中国和日本16~70岁控制不佳的部分性癫■发作患者中开展的随机、双盲、安慰剂对照临床试验。在双盲试验中完成维持期的患者可进入开放标签扩展性试验EP0009(NCT01832038)。本研究针对两项试验中的中国536例部分性癫■发作患者进行分析,经剔除筛选失败的130例患者,共计406例中国部分性癫■发作患者入组,随机分为安慰剂组(136例)、拉考沙胺200 mg·d^-1组(136例)和拉考沙胺400 mg·d^-1组(134例)。结果406例中358例(88.2%)完成试验。从基线期至维持期,拉考沙胺400 mg·d^-1组和拉考沙胺200 mg·d^-1组每28 d癫■发作频次分别减少43.1%和33.6%,与安慰剂组比较,差异有显著统计学意义(P<0.001)。拉考沙胺400 mg·d^-1组、拉考沙胺200 mg·d^-1组、安慰剂组治疗期间发生率>10%的不良事件为头晕(分别为33.8%、14.7%、11.0%)和鼻咽炎(分别为11.3%、10.3%、8.8%)。同时联合使用钠离子通道阻滞剂(SCBs)患者的头晕发生率高于联合使用非SCBs患者。拉考沙胺联合使用SCBs时,滴定期患者的头晕发生率高于维持期。开放标签试验加量策略灵活,头晕发生率降低,患者的耐受性提高。结论拉考沙胺(200和400 mg·d^-1)用于中国控制不佳的部分性癫■发作患者有效,耐受性良好。 | 洪震 廖卫平 孟红梅 杜新鲁 Toru Osakabe Hiroshi Sasamoto Frank Tennigkeit 王文敏 王学峰 张黎明 周列民 张颖 | 2019 | 中国临床神经科学2019，27，4： | 3 |
| 6 | Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver显示文摘 | Hiroya Yamada Koji Suzuki Naohiro Ichino Yoshitaka Ando Akira Sawada Keisuke Osakabe Keiko Sugimoto Koji Ohashi Ryouji Teradaira Takashi Inoue Nobuyuki Hamajima Shuji Hashimoto | 2013 | Clinica Chimica Acta2013，，： | 3 |
| 7 | Effects of cacao liquor proanthocyanidins on PhIP-induced mutagenesis in vitro, and in vivo mammary and pancreatic tumorigenesis in female Sprague-Dawley rats 显示文摘 | Yamagishi M Natsume M Osakabe N | 2002 | Cancer Lett2002，185，： | 2 |
| 8 | Receptor-like protein kinase 2 ( RPK 2 ) is a novel factor controlling anther de- velopment in Arabidopsis thaliana 显示文摘 | MIZUNO S OSAKABE Y MARUYAMA K | 2007 | Plant Journal2007，50，5： | 1 |
| 9 | Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma,and is degraded and metabolized to conjugated forms of caffeic acid,ferulic acid and m-coumaric acid显示文摘 | Baba S Osakabe N Natsume M | 2004 | Life Sci2004，75，2： | 1 |
| 10 | Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of perilla frutescens extract in humans显示文摘 | Baba S Osakabe N Natsume M | 2005 | Eur J Nutr2005，44，1： | 1 |
| 11 | Water flow distri- bution in horizontal header contaminated with bubbles 显示文摘 | M Osakabe T Hamada S Horiki | 1999 | International Journal of Multiphase Flow1999，25，： | 1 |
| 12 | Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma,and is degraded and metabolized to conjugated forms of caffeic acid,ferulic acid and m-coumaric acid显示文摘 | Baba S Osakabe N Natsume M | 2004 | Life Sci2004，75，2： | 1 |
| 13 | Thin flow header to distribute feed water for compact heat exchanger 显示文摘 | S Horiki T Nakamura M Osakabe | 2004 | Experimental Thermal and Fluid Science2004，28，： | 1 |
| 14 | Rosmarinic acid in-hibits lung injury induced by diesel exhaust particles 显示文摘 | TAKOO H OSAKABE N SASA N | 2003 | FreeRadical Biology and Medicine2003，34，8： | 1 |
| 15 | Functional analysis of an Arabidopsis transcription factor, DREB2A, involved in drought-responsive gene expression显示文摘 | SAKUMA Y MARUYAMA K OSAKABE K | 2006 | The Plant Cell2006，18，5： | 1 |
| 16 | Reduction ofliver stiffness by antiviral therapy in chronic hepatitis B显示文摘 | Osakabe K Ichino N Nishikawa T | 2011 | J Gastroenterol2011，46，11： | 1 |
| 17 | Isolation and characterization of the RAD54 gene from Arabidopsis thaliana显示文摘 | OSAKABE K ABE K YOSHIOKA T | 2006 | The plant journal2006，48，6： | 1 |
| 18 | Functional analysis of an Arabidopsis transcription factor,DREB2A,involved in drought-re sponsive gene expression显示文摘 | Sakuma Y Maruyama K Osakabe Y | 2006 | Plant Cell2006，18，5： | 1 |
| 19 | Magnetic resonance inmging findings in cerebral fat embolism:correlation with clinical manifestations 显示文摘 | Takahashi M Suzuki R Osakabe Y | 1999 | J Trauma1999，46，2： | 1 |
| 20 | Evaluation of posterior capsule opacification us- ing a new posterior view method in rabbits: single-piece acrylic versus 3-pieceacrylic intraocular lens显示文摘 | Nishi O Nishi K Osakabe Y | 2005 | J Cataract Refract Surg2005，31，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员